Biotechnology

Edwards Lifesciences Corporation , a world leader in products and technologies to treat advanced cardiovascular disease, today reported net income for the quarter ended September 30, 2008 of $32.9 million, or $0.56 per diluted share, compared to net inco

BioPharm Insight, a leading provider of information to the life sciences industry, announced today the immediate availability of its proprietary Clinical Trials Network to its growing suite of information products.

InfoMedics, Inc., the patient feedback company, today announced the launch of a unique solution to the adherence problem: Adherence Driver™, the first brand-specific adherence program to conduct a detailed analysis of each patient's unique behaviora

UC Davis Medical Center and Cedars-Sinai Medical Center in Los Angeles.

Delcath Systems, Inc. a leading developer of regional therapy for liver cancer announced today that President and CEO Richard Taney will participate in a Panel Discussion on 'Combination Products: A Convergence of Technologies and Market Opportunities' a

PharmaCom BioVet, Inc. is pleased to announce its plans with IsoTherapeutics Group, LLC to explore the latest ground-breaking direct injection liquid brachytherapy therapeutic radioisotope procedures* for use within its canine cancer treatment centers.

Cleveland BioLabs, Inc. today announced that the Company will present at the 2008 BIO Investor Forum in San Francisco, October 29-31, 2008. The conference will be held at The Palace Hotel in San Francisco. Management will be available to meet with invest

THIS PRESS RELEASE SHOULD NOT BE CONSTRUED AS AN OFFER TO SELL SECURITIES IN THE UNITED STATES.

According to the recently published report, 'Investigator-Initiated Trials: Building Superior IIT Capabilities,' developed by pharmaceutical market research leader Cutting Edge Information, first-look screening activities eliminate 11% of all IIT proposa

As part of the Company's continued growth plan, Franek Technologies, the leader in certified Category III-3 Laboratory Battery Backup Power Protection Systems , is in the final stages of completing its ISO 9001-2000 certification. A central component of

CTD Holdings, Inc. announced today that the Board of Directors has approved a $150,000 share repurchase program. The timing of the open market purchases was not disclosed by the Company.

Applied DNA Sciences, Inc. , a provider of DNA-based security solutions, today announced that it's President & CEO, Dr. James Hayward, will invest an additional $500,000, increasing his total financial commitment in the company to $1.35 million. This

Auxilium Pharmaceuticals, Inc. today announced that executive management will participate in the Oppenheimer Healthcare Conference to be held November 3 - 4 at The Waldorf-Astoria in New York City. Mr. Armando Anido, Chief Executive Officer, is scheduled

NaturalNano , and Oxford Performance Materials , today announced that the companies have signed an exclusive joint development and supply agreement. Within the scope of the agreement, OPM and NaturalNano will work to develop products, applications and ma

The North Texas Enterprise Center for Medical Technology , a business accelerator for medical device and healthcare related technology firms, announced today that it has launched a comprehensive nationwide marketing program for pre-leasing space in its n